Index of artpub/2024/313092/

Garcia-Moll, Xavier
A cost-effectiveness analysis of empagliflozin for heart failure patients across the full spectrum of ejection fraction in Spain : combined results of the EMPEROR-Preserved and EMPEROR-Reduced trials
2024
https://ddd.uab.cat/record/313092